tirzepatide success pros and cons for weight loss A 72-week trial compared the two leading GLP-1 medications in adults with obesity (no diabetes). The results: ✓ Tirzepatide: 20.2% ✓ Semaglutide: 13.7% weight loss Keys to Successful Weight Loss

however we cannot establish causality based on these retrospective results and further prospective investigations are needed. In the second study, researchers focused on examining how GLP-1 use might impact the risk of developing osteoporosis, gout, or osteomalacia (bone softening) in people with type 2 diabetes and obesity

For peptides to show optimal effects in research settings consistent physical stimulus is necessary as mechanical stress stimulates natural release of growth hormone and potentially enhances the observed effects in research models

That combination is tiring

So, my iron levels (and ferritin and transferrin) were the first focus of my attention